Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$18.7M
1 round on record
Latest round
$18.7M
Venture round · May 2022 · 4 yr ago
Team
13
US Form 5500 (plan participants) · Dec 2025 · -46% in a year
Backers
1
Arboretum Ventures
The money's age
Long since its last round
52 months since the last round · not hiring
Momentum
0/100
no fresh signals
Funding rounds
RoundDateAmountInvestorsSource
Venture round May 2022 $18.7M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Enumera Molecular, Inc. sec
Founders and leadersfrom filings, registers and the company's site
Matthew CooperExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Scipher MedicineVenture round $5.8M · 2 yr ago • Founded 2013 • 201-500 employees
Transforming Treatment in Immunology. Living at the crossroads of precision medicine and AI, Scipher Medicine is a precision immunology…
DoMore DiagnosticsFounded 2020 • 1-10 employees
DoMore Diagnostics is on a mission to transform cancer diagnostics with artificial intelligence to improve patient care and make drug…
RareCyteVenture round $13.2M · 3 yr ago • Founded 2009 • 201-500 employees
RareCyte, Inc. is a Seattle-based precision biology company developing advanced platforms and services for spatial biology and liquid…
GenomateConvertible Note $2M · 18 mo ago • Founded 2022 • 51-200 employees
Genomate helps physicians find the right targeted therapy for every cancer patient based on the individual molecular profile of their…
NomicSeries B $42M · 2 yr ago • 11-50 employees
Discover Omni 1000, the revolutionary proteomics platform offering 1000 high-fidelity proteins for cost-effective and rapid analysis in any…
ValarlabsVenture round $4.1M · 4 yr ago • Founded 2021 • 11-50 employees
Valar Labs makes diagnostics that use AI to interpret solid tumors and deliver insights, so physicians and patients can make informed…

Overview

At Enumera Molecular we are transforming the field of complex diagnostic testing to a simpler, cost-effective tool for physicians to benefit patient care.

People

Matthew Cooper
Executive Officer, Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Ann Arbor United States
HQ
Enumera Molecular
50-200 est. staff
600 S Wagner Rd,, Ann Arbor, MI 48103
company site

Financials

Total raised
$18.7M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2022 $18.7M Details